Thai Breast Disease Society,
In the first-line or second-line setting, CDK4/6 inhibitors plus hormone therapies are better than standard hormone therapies…
In the first-line or second-line setting, CDK4/6 inhibitors plus hormone therapies are better than standard hormone therapies…
In the first-line or second-line setting, CDK4/6 inhibitors plus hormone therapies are better than standard hormone therapies…
https://www.sciencedirect.com/science/article/abs/pii/S1470204519304206 這篇Lancet Oncology最新的network meta-analysis比較的治療種類數目之多令人嘆為…
閉経後/ホルモンレセプター陽性/HER2陰性転移性乳がんの初回および二次治療において、progression-free survival をもっとも改善するのは CDK4/6 阻害剤とホルモン療法の併用であり、これを上回るホルモン療法あるいは化学療法レジメン…